Last Updated: Tuesday, July 29, 2014, 18:42
A new study has demonstrated how a first-ever controlled malaria infection clinical trial in Africa has paved a way for the development of anti-malarial drugs and vaccines.
Last Updated: Wednesday, July 23, 2014, 17:11
If you are allergic to dust mites, here comes the help. Researchers have now developed a vaccine that can combat dust-mite allergies by switching on the body`s immune response.
Last Updated: Friday, July 18, 2014, 15:13
The vaccine for HIV being developed by the Norwegian vaccine company Bionor Pharma could soon be a reality as researchers have found that median HIV viral load reduction more than doubled among participants with high anti-C5/gp41732-744 antibody levels.
Last Updated: Friday, July 18, 2014, 15:11
You may soon look at cat poop in a different light as it may hold the key to cancer cure.
Last Updated: Thursday, July 17, 2014, 12:57
A study has revealed the concept of development of the world`s first T-cell peptide-based vaccine for heart disease the number one killer in the nation.
Last Updated: Sunday, July 13, 2014, 17:32
The large cases of polio virus in Pakistan pose a threat to its neighbours such as India, the world`s leading polio vaccine manufacturers has warned.
Last Updated: Sunday, July 13, 2014, 13:35
A potential new dengue vaccine - the first to reach phase 3 clinical testing - has demonstrated that it provides 56 per cent protection against the disease in Asian children, according to a new research.
Last Updated: Friday, July 11, 2014, 13:03
The first dengue vaccine candidate (CYD-TDV) has shown moderate protection (56 percent) against the disease in Asian children in phase 3 clinical testing, according to a new research.
Last Updated: Friday, July 11, 2014, 12:59
An extra dose of inactivated polio vaccine (IPV) helps to boost immunity in children less than 5 years to the poliovirus and should be added to vaccination programmes in polio-endemic countries and those facing a high risk of imported cases, according to a new research.
Last Updated: Tuesday, June 17, 2014, 19:49
Two global pharmaceutical firms - Hilleman Laboratories and Gotovax AB - Tuesday joined hands to develop affordable oral cholera vaccine.
Last Updated: Tuesday, June 17, 2014, 17:21
This vaccine candidate is suited for geographies with the high cholera burden such as Africa and South Asia.
Last Updated: Wednesday, June 04, 2014, 13:00
Researchers have figured out how to disable a part of the SARS virus responsible for hiding it from the immune system; a critical step in developing a vaccine against the deadly disease.
more videos >>